The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP).

The expression of the APP (amyloid precursor protein), which plays a key role in the development of AD (Alzheimer's disease), is regulated by a variety of cellular mediators in a cell-dependent manner. In this study, we present evidence that p53 regulates the expression of the APP gene in neuroblastoma cells. Transient expression of ectopic p53, activation of endogenous p53 by the DNA-damaging drug camptothecin or Mdm2 (murine double minute 2) depletion decreases the intracellular levels of APP in murine N2abeta neuroblastoma cells. This effect was also observed in primary cultures of rat neurons as well as in SH-SY5Y cells, a human neuroblastoma cell line. Transient transfection studies using plasmids that contain progressive deletions of the 5' region of the gene demonstrate that p53 represses APP promoter activity through a mechanism that is mediated by DNA sequences located downstream of the transcription start site (+55/+101). Accordingly, expression of a dominant-negative p53 mutant significantly increases the transcriptional activity of the APP promoter. In addition, results obtained in gel mobility-shift assays show that p53 does not bind to the +55/+101 APP region, although it reduces binding of the transcription factor Sp1 (stimulating protein 1). Reduction of Sp1 binding after activation of p53 with camptothecin was also observed in chromatin immunoprecipitation assays. Altogether, our results strongly suggest a mechanism by which p53 precludes binding of Sp1 to DNA, and therefore the stimulation of the APP promoter by this transcription factor.

[1]  J. Trejo,et al.  A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's beta-amyloid precursor protein gene. , 1994, The Journal of biological chemistry.

[2]  T. Tabira,et al.  Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease , 2005 .

[3]  S. Pradhan,et al.  Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells* , 2007, Journal of Biological Chemistry.

[4]  M. Henriksson,et al.  Camptothecin‐induced apoptosis is enhanced by Myc and involves PKCdelta signaling , 2007, International journal of cancer.

[5]  A. Chicas,et al.  p53 represses Sp1 DNA binding and HIV-LTR directed transcription. , 1997, Cellular and molecular biology.

[6]  Á. Pascual,et al.  Thyroid Hormone Negatively Regulates the Transcriptional Activity of the β-Amyloid Precursor Protein Gene* , 1998, The Journal of Biological Chemistry.

[7]  L. Mucke,et al.  Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Cheng,et al.  Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Selkoe,et al.  Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. , 1994, Annual review of cell biology.

[10]  M. Mattson,et al.  Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.

[11]  P. S. St George-Hyslop,et al.  Presenilin-Dependent γ-Secretase-Mediated Control of p53-Associated Cell Death in Alzheimer's Disease , 2006, The Journal of Neuroscience.

[12]  M. Díaz-Guerra,et al.  Transcription of the NR1 Subunit of the N-Methyl-d-aspartate Receptor Is Down-regulated by Excitotoxic Stimulation and Cerebral Ischemia * , 2005, Journal of Biological Chemistry.

[13]  A. Torgeman,et al.  Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. , 2001, Virology.

[14]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[15]  S. Deeb,et al.  Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity. , 1992, Biochemical and biophysical research communications.

[16]  P. Greengard,et al.  Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. , 1994, The Journal of biological chemistry.

[17]  N. Andrews,et al.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.

[18]  J. Wands,et al.  Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease , 1997, Journal of the Neurological Sciences.

[19]  Julia Tischler,et al.  The Tumor Suppressor p53 and Histone Deacetylase 1 Are Antagonistic Regulators of the Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1 Gene , 2003, Molecular and Cellular Biology.

[20]  S. Kyo,et al.  Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  Y. Sakaki,et al.  Genomic organization of the human-amyloid beta-protein precursor gene. , 1990, Gene.

[22]  K. Yoshikawa,et al.  Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor , 1992, Nature.

[23]  B. Desvergne,et al.  Functional characterization and receptor binding studies of the malic enzyme thyroid hormone response element. , 1991, The Journal of biological chemistry.

[24]  P. Greengard,et al.  Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Shirley M. Taylor,et al.  p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding. , 2003, Cancer research.

[26]  J. Puymirat,et al.  Overexpression of the beta 1 thyroid receptor induces differentiation in neuro-2a cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Tabira,et al.  Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells. , 1993, Brain research. Molecular brain research.

[28]  Á. Pascual,et al.  A response unit in the first exon of the beta-amyloid precursor protein gene containing thyroid hormone receptor and Sp1 binding sites mediates negative regulation by 3,5,3'-triiodothyronine. , 2004, Molecular endocrinology.

[29]  D. Kardassis,et al.  Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis. , 2005, The Biochemical journal.

[30]  H. Samuels,et al.  Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression , 1997, Molecular and cellular biology.

[31]  N. Robakis,et al.  The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences. , 1991, Brain research. Molecular brain research.

[32]  C. Masters,et al.  Retinoic acid induced differentiated neuroblastoma cells show increased expression of the βA4 amyloid gene of Alzheimer's disease and an altered splicing pattern , 1990, FEBS letters.

[33]  P. George-Hyslop,et al.  The γ /η-Secretase-Derived APP Intracellular Domain Fragments Regulate p53 , 2007 .

[34]  C. Ohlsson,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society p53 Regulates Insulin-Like Growth Factor-I (IGF-I) Receptor Expression and IGF-I-Induced Tyrosine Phosphorylation in an Osteosarcoma Cell Line: Interaction between p53 and Sp1 , 2022 .

[35]  A. LeBlanc,et al.  Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neurons , 2002, The Journal of cell biology.

[36]  K. Kinzler,et al.  Definition of a consensus binding site for p53 , 1992, Nature Genetics.

[37]  Á. Pascual,et al.  Nerve Growth Factor and Ras Regulate β‐Amyloid Precursor Protein Gene Expression in PC12 Cells , 1996, Journal of neurochemistry.

[38]  P. Greengard,et al.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Y. Kitamura,et al.  Changes of p53 in the brains of patients with Alzheimer's disease. , 1997, Biochemical and biophysical research communications.

[40]  F. LaFerla,et al.  Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. , 1996, The Journal of clinical investigation.

[41]  A. Zmijewska,et al.  Muscarinic Receptor Activation Protects Cells from Apoptotic Effects of DNA Damage, Oxidative Stress, and Mitochondrial Inhibition* , 2003, The Journal of Biological Chemistry.